New research undertaken by the University of Utah Health has found that one of the most common health care-associated infections spreads in intensive care units more than three times more than ...

Following successful trials at Geisinger Medical Center and Geisinger Wyoming Valley Medical Center, the health system will ...

Vancomycin appeared to top placebo for lowering Clostridioides difficile infection (CDI) recurrence rates in patients taking ...

Human immunodeficiency virus (HIV) is a germ that causes a lifelong infection that slowly weakens the immune system. Though the infection is lifelong, medicines can keep the virus in check and ...

Treating infections with infections Vancomycin-resistant Enterococcus faecium (VRE) is a frequent cause of bacteremia in immunocompromised patients and there exists only two antibiotics that are ...

Patients colonized with AMR pathogens showed high risk for infection with the same pathogen for up to 2 years, indicating a time window for decolonization interventions.

A recent study reveals that an antibiotic used for liver disease patients may increase their risk of contracting a dangerous superbug. An international team of researchers has discovered that ...

Acurx Pharma receives positive regulatory guidance from EMA for ibezapolstat phase 3 programme for C. difficile infection Staten Island, New York Tuesday, January 7, 2025, 18:00 Hrs [IST] Acurx ...